Clinical Trials

Ultrasound and Bubbles: Singapore Trials Non-Invasive Tumor Treatment
Research & Development Ultrasound and Bubbles: Singapore Trials Non-Invasive Tumor Treatment

As a promising new frontier in cancer treatment, histotripsy represents a significant advancement in non-invasive medical procedures aimed at eliminating tumors. The technique utilizes bubbles generated via precise ultrasound waves to target and destroy specific cancer cells. Notably, histotripsy

Speech Neuroprosthesis Enables Near-Real-Time Communication
Tech & Innovation Speech Neuroprosthesis Enables Near-Real-Time Communication

The collaborative research effort between UC Berkeley and UC San Francisco introduces a groundbreaking speech neuroprosthesis designed to restore naturalistic speech for individuals experiencing severe paralysis. This pioneering technology addresses the critical issue of latency, allowing brain

FDA vs. EMA: Which Agency Balances Innovation and Safety Better?
Management & Regulatory FDA vs. EMA: Which Agency Balances Innovation and Safety Better?

Innovation thrives at the intersection of regulatory flexibility and robust oversight, especially within the dynamic field of first-in-class drugs. Today, we delve into this critical topic with Ivan Kairatov, a seasoned biopharma expert with extensive experience in research and development. With a

Can Relacorilant and Nab-Paclitaxel Change Ovarian Cancer Treatment?
Research & Development Can Relacorilant and Nab-Paclitaxel Change Ovarian Cancer Treatment?

The recent results from the pivotal Phase 3 ROSELLA trial mark a significant development in the battle against platinum-resistant ovarian cancer. Corcept Therapeutics announced that the trial successfully demonstrated the efficacy of combining relacorilant with nab-paclitaxel chemotherapy,

Can AI ECG Models Revolutionize NSTEMI Heart Attack Diagnosis?
Tech & Innovation Can AI ECG Models Revolutionize NSTEMI Heart Attack Diagnosis?

Advancements in artificial intelligence (AI) have facilitated significant progress in heart attack diagnosis, specifically through an AI model trained to identify blocked coronary arteries using electrocardiogram (ECG) readings. This groundbreaking technology has been found to outperform human

Can AI-Powered Digital Twins Revolutionize ALS Clinical Trials?
Research & Development Can AI-Powered Digital Twins Revolutionize ALS Clinical Trials?

The rapid advancement of artificial intelligence (AI) has made significant strides in many sectors, and the realm of healthcare is no exception. Among the promising innovations is the use of AI-powered digital twins in clinical trials, particularly those targeting complex diseases like Amyotrophic

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later